Literature DB >> 31879976

Development and validation of a nomogram for predicting overall survival of node-negative ampullary carcinoma.

Xi-Tai Huang1, Chen-Song Huang1, Wei Chen1, Jian-Peng Cai1, Tian-Tian Gan1, Ying Zhao1, Qi Liu1, Li-Jian Liang1, Xiao-Yu Yin1.   

Abstract

BACKGROUND: The accuracy of the current staging system for predicting the overall survival (OS) of patients with ampullary carcinoma (AC) is still unsatisfactory, especially in node-negative (N0) patients. We aimed at establishing a nomogram to accurately predict OS in N0 AC.
METHODS: This study enrolled 697 N0 AC patients from the Surveillance, Epidemiology, and End Results database (design cohort [DC], n = 697) and the First Affiliated Hospital of Sun Yat-sen University (validation cohort [VC], n = 112), who underwent surgical resection. The nomogram was established by using prognostic factors determined by univariate and multivariate regression analyses.
RESULTS: The nomogram for OS was developed by using four independent prognostic factors, including age, grade, T stage, and a number of examined lymph nodes. The C-index of a nomogram for OS in DC and VC was 0.665 and 0.731, respectively. Calibration curves showed good consistency of the nomogram. The nomogram had a better accuracy in predicting OS compared with conventional staging system (P < .05). On the basis of nomogram-predicted scores, the patients were stratified into groups with different risk. The OS of low-risk patients was significantly longer than high-risk ones (P ≤ .010).
CONCLUSIONS: The nomogram could be used to predict the OS of N0 AC. It could help guide further treatment in clinical practice.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  ampullary carcinoma; lymph node; nomogram; prediction; prognosis

Mesh:

Year:  2019        PMID: 31879976     DOI: 10.1002/jso.25816

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.

Authors:  Daniel Weiss Vilhordo; Cleandra Gregório; Dirceu Felipe Valentini; Maria Isabel Albano Edelweiss; Diego Mendonça Uchoa; Alessandro Bersch Osvaldt
Journal:  J Gastrointest Cancer       Date:  2021-09

2.  Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology.

Authors:  Matteo Palmeri; Niccola Funel; Gregorio Di Franco; Niccolò Furbetta; Desirée Gianardi; Simone Guadagni; Matteo Bianchini; Luca E Pollina; Claudio Ricci; Marco Del Chiaro; Giulio Di Candio; Luca Morelli
Journal:  World J Gastroenterol       Date:  2020-11-21       Impact factor: 5.742

3.  The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.

Authors:  Shuxin Sun; Chaobin He; Jun Wang; Xin Huang; Jiali Wu; Shengping Li
Journal:  BMC Cancer       Date:  2020-10-10       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.